pargyline has been researched along with Cataract, Membranous in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Befani, O | 1 |
| Missiroli, F | 1 |
| Mondovi, B | 1 |
| Mueller, FO | 1 |
| Magos, L | 1 |
2 other studies available for pargyline and Cataract, Membranous
| Article | Year |
|---|---|
Histaminase (diamine oxidase) activity in human cataract.
Topics: Amine Oxidase (Copper-Containing); Amino Acid Oxidoreductases; Cataract; Enzyme Inhibitors; Humans; | 1999 |
Reversible lenticular opacities induced in rats by emotional stress.
Topics: Animals; Cataract; Catecholamines; Epinephrine; Humans; Male; Pargyline; Rats; Stress, Psychological | 1970 |